Cameron Turtle sold $1.4M of SYRE stock

Cameron Turtle, Chief Executive Officer of Spyre Therapeutics, Inc. (SYRE), sold 15,000 shares of SYRE stock worth $1.4M, per an SEC Form 4 filed Oct 3, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Oct 1, 2026, 2 days before it was made public.

SYRE has moved +15.6% since the trade date, from $89.93 to $104.00 (Nov 13, 2026 close).